Individual Study / Yu et al.; J Clin Endocrinol Metab. 2014

Continuous Glucose Monitoring Effects on Maternal Glycemic Control and Pregnancy Outcomes in Patients With Gestational Diabetes Mellitus: A Prospective Cohort Study

Continuous Glucose Monitoring Effects on Maternal Glycemic Control and Pregnancy Outcomes in Patients With Gestational Diabetes Mellitus: A Prospective Cohort Study

Initiatives -
The objective was to evaluate the effectiveness of CGM on maternal glycemic control and pregnancy outcomes in patients with GDM . Note: All published information has been collected from the article referenced in the Marker Paper box below. Therefore, there may be variations with more advanced versions of the study.
Start Year
2011
Funding
This work was supported by a grant from Guangdong Science and Technology Department, China (2011B31800264). J.N. is the guarantor of this work and, as such, had full access to all the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis.

Design

Study design
Patients' cohort

Marker Paper

Yu F, Lv L, Liang Z, et al. Continuous glucose monitoring effects on maternal glycemic control and pregnancy outcomes in patients with gestational diabetes mellitus: a prospective cohort study. J Clin Endocrinol Metab. 2014;99(12):4674‐4682. doi:10.1210/jc.2013-4332

PUBMED 25057872

Number of participants

Number of participants
340
Number of participants with biosamples

Access

Availability of data and biosamples

Data
Biosamples
Other

Timeline

Population

The present study, conducted by the Department of Obstetrics of GuangDong Women and Children Hospital in Guangzhou, China, enrolled a total of 340 pregnant Han Chinese women with GDM at 24 to 28 gestational weeks of a singleton pregnancy. Patient demographics included age, parity, childbearing history, past medical history, prepregnancy body weight, height, blood pressure, and fasting glucose concentrations in the first trimester.
Selection Criteria
Gender
women
Pregnant women
  • Second Trimester
  • Third Trimester
Newborns
Twins
Countries
  • China
Ethnic Origin
Health Status
  • The exclusion criteria included a diagnosis of diabetes before knowledge of pregnancy, a fasting glucose level of more than 5.1 mmol/L in the first trimester.
Other criteria
Reluctance to be examined regularly in the Department of Obstetrics of GuangDong Women and Children Hospital, delivery of the infant in another hospital, multiple pregnancies, and a diagnosis of overt diabetes during the current pregnancy or complicated pregnancies as a consequence of other medical diseases.

Recruitment

Sources of recruitment
  • Specific population

Number of participants

Number of participants
340
Number of participants with biosamples
Data Collection Event
All patients were taught to self-monitor their blood glucose levels 7 times a day with the Abbott Optium Xceed glucometer and the self-code data submitted into the patient's private meter.
Start Date
2011-04
End Date
2012-08
Data sources
  • Mobile data collection
    • Abbott Optium Xceed glucometer